Effect of Education program on improving patient reported recovery profile post Hyperthermia Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis

Background; Cytoreductive surgery (CRS) and hyperthermic intraperitoneal
chemotherapy (HIPEC) is associated with improved survival for patients with
abdominal malignancies with peritoneal dissemination .This study aimed to
evaluate the effect of Education program on improving patient reported recovery
profile post Hyperthermia Intraperitoneal Chemotherapy for Peritoneal
Carcinomatosis .Design: Quasi-experimental design was utilized in this study .
Setting :The study was carried out at intensive care unit at the National Cancer
Institute (NCI), Cairo University. During the period from the beginning of January
2019 till the beginning of January 2020 Sample :Purposive sample of 97 patients
Tools :Two tools used to collect the study data .These are structured interview
questionnaire to assess patients' knowledge regarding Hyperthermia Intraperitoneal
Chemotherapy, and Patient-Reported Recovery Profile Results :Showed that there
was statistically significant difference in term of increased knowledge level among
study group , as well as a increase in total mean score in patient-reported recovery
Profile pre ,immediately and after education program implementation ,shows high
statistically significant negative correlation between of length of hospital stay and
reported recovery profile immediately post and after program implementation
inverse relationship. Conclusion :Implementing a designed education program for
patients with Hyperthermia Intraperitoneal Chemotherapy was effective in
improving knowledge, and patient-reported recovery. Shows high statistically
significant negative correlation between length of hospital stay and reported
recovery profile immediately post and after program implementation.
Recommendation :additional demographic variables. Manuals, information
booklets and self-instruction module should be developed in areas of Hyperthermia
Intraperitoneal Chemotherapy management